Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0299 | ||||
Gene Name | SLC35D2 | ||||
Protein Name | UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | HFRC; HFRC1; Homolog of Fringe connection protein 1; SLC35D2; SQV7-like protein; SQV7L; Solute carrier family 35 member D2; UDP-galactose transporter-related protein 8; UGTrel8 | ||||
DT Family | Drug/Metabolite Transporter (DMT) Superfamily | ||||
UDP-glucuronate/UDP-N-acetylgalactosamine Transporter (UGnT) Family | |||||
Tissue Specificity | Highly expressed in heart, kidney, smallintestine, placenta, lung and peripheral blood leukocyte. Weaklyexpressed in skeletal muscle and spleen. Not expressed in brain,colon and thymus. | ||||
Function | This antiporter transporting nucleotide sugars such as UDP-N-acetylglucosamine (UDP-GlcNAc), UDP-glucose (UDP-Glc) and GDP-mannose (GDP-Man) pooled in the cytosol into the lumen of the Golgi in exchange for the corresponding nucleosides monophosphates (UMP for UDP-sugars and GMP for GDP-sugars). | ||||
Endogenous Substrate(s) | GDP-mannose; UDP-N-acetylglucosamine | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.